Obesity and Eye Diseases

Survey of Ophthalmology

Volumn 52, Issue 2, 2007, Pages 180-195

  Cheung, Ning ^a,b   Wong, Tien Y ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

age related maculopathy; body mass index; cataract; eye disease; glaucoma; obesity; pseudotumor celebri; retinal artery occlusion; retinal vein occlusion; retinopathy

Indexed keywords

ARTICLE; BODY MASS; BRAIN PSEUDOTUMOR; CATARACT; COMORBIDITY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; ENTROPION; EPIDEMIC; EYE DISEASE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; OBESITY; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; RETINA MACULOPATHY; RISK FACTOR;

BODY MASS INDEX; EYE DISEASES; HUMANS; OBESITY;

EID: 33847693532     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2006.12.003     Document Type: Article

References (229)

1. Risk factors associated with age-related nuclear and cortical cataract: a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. Ophthalmology 108 (2001) 1400-1408
2. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107 (2000) 2224-2232
3. Abramson N., and Abramson S. Hypercoagulability: clinical assessment and treatment. South Med J 94 (2001) 1013-1020
4. Agata J., Masuda A., Takada M., et al. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 10 (1997) 1171-1174
5. Aiello L.P., Avery R.L., Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 (1994) 1480-1487
6. Alam A.A., Mitwalli A.H., Al-Wakeel J.S., et al. Plasma fibrinogen and its correlates in adult Saudi population. Saudi Med J 25 (2004) 1593-1602
7. Backhouse O., Parapia L., Mahomed I., et al. Familial thrombophilia and retinal vein occlusion. Eye 14 Pt 1 (2000) 13-17
8. Ballard D.J., Melton L.J., Dwyer M.S., et al. Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9 (1986) 334-342
9. Bengtsson B., and Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma 14 (2005) 135-138
10. Bergman B., Nilsson-Ehle H., and Sjöstrand J. Ocular changes, risk markers for eye disorders and effects of cataract surgery in elderly people: a study of an urban Swedish population followed from 70 to 97 years of age. Acta Ophthalmol Scand 82 (2004) 166-174
11. Bhuyan K.C., Bhuyan D.K., and Podos S.M. Lipid peroxidation in cataract of the human. Life Sci 38 (1986) 1463-1471
12. Bianchini F., Kaaks R., and Vainio H. Weight control and physical activity in cancer prevention. Obes Rev 3 (2002) 5-8
13. Bonomi L., Marchini G., Marraffa M., et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 107 (2000) 1287-1293
14. Bouloumie A., Marumo T., Lafontan M., et al. Leptin induces oxidative stress in human endothelial cells. FASEB J 13 (1999) 1231-1238
15. Brazis P.W., and Lee A.G. Elevated intracranial pressure and pseudotumor cerebri. Curr Opin Ophthalmol 9 (1998) 27-32
16. Broadway D.C., and Drance S.M. Glaucoma and vasospasm. Br J Ophthalmol 82 (1998) 862-870
17. Bulpitt C.J., Hodes C., and Everitt M.G. Intraocular pressure and systemic blood pressure in the elderly. Br J Ophthalmol 59 (1975) 717-720
18. Caballero M., Liton P.B., Epstein D.L., et al. Proteasome inhibition by chronic oxidative stress in human trabecular meshwork cells. Biochem Biophys Res Commun 308 (2003) 346-352
19. Caldwell R.B., Bartoli M., Behzadian M.A., et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 6 (2005) 511-524
20. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
21. Caulfield L.E., West S.K., Barrón Y., et al. Anthropometric status and cataract: the Salisbury Eye Evaluation project. Am J Clin Nutr 69 (1999) 237-242
22. Chatterjee A., Milton R.C., and Thyle S. Prevalence and aetiology of cataract in Punjab. Br J Ophthalmol 66 (1982) 35-42
23. Chaturvedi N., and Fuller J.H. Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care 18 (1995) 766-774
24. Chaturvedi N., Sjoelie A.K., Porta M., et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 24 (2001) 284-289
25. Chew E.Y. Diabetic retinopathy and lipid abnormalities. Curr Opin Ophthalmol 8 (1997) 59-62
26. Chew E.Y., Klein M.L., Ferris F.L., et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 114 (1996) 1079-1084
27. Chopdar A., Chakravarthy U., and Verma D. Age related macular degeneration. BMJ 326 (2003) 485-488
28. Clemons T.E., Milton R.C., Klein R., et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112 (2005) 533-539
29. Cohen R.A., Hennekens C.H., Christen W.G., et al. Determinants of retinopathy progression in type 1 diabetes mellitus. Am J Med 107 (1999) 45-51
30. Cole T.J., Bellizzi M.C., Flegal K.M., et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320 (2000) 1240-1243
31. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334 (1996) 292-295
32. Cushman M., Yanez D., Psaty B.M., et al. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators. Am J Epidemiol 143 (1996) 665-676
33. Cusick M., Chew E.Y., Chan C.C., et al. Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Ophthalmology 110 (2003) 2126-2133
34. D'Amico D.J., Goldberg M.F., Hudson H., et al. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology 110 (2003) 2372-2383 discussion 2384-5
35. De Block C.E., De Leeuw I.H., and Van Gaal L.F. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care 28 (2005) 1649-1655
36. Delcourt C., Michel F., Colvez A., et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 8 (2001) 237-249
37. Dielemans I., Vingerling J.R., Algra D., et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 102 (1995) 54-60
38. Dielemans I., Vingerling J.R., Wolfs R.C., et al. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 101 (1994) 1851-1855
39. Dietz W.H. Overweight in childhood and adolescence. N Engl J Med 350 (2004) 855-857
40. Dorchy H., Claes C., and Verougstraete C. Risk factors of developing proliferative retinopathy in type 1 diabetic patients: role of BMI. Diabetes Care 25 (2002) 798-799
41. Dowse G.K., Humphrey A.R., Collins V.R., et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 147 (1998) 448-457
42. Duntas L.H., Popovic V., and Panotopoulos G. Adiponectin: novelties in metabolism and hormonal regulation. Nutr Neurosci 7 (2004) 195-200
43. Eckel R.H., and Krauss R.M. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 97 (1998) 2099-2100
44. Evereklioglu C., Doganay S., Er H., et al. Serum leptin concentrations are decreased and correlated with disease severity in age-related macular degeneration: a preliminary study. Eye 17 (2003) 350-355
45. Fasshauer M., Paschke R., and Stumvoll M. Adiponectin, obesity, and cardiovascular disease. Biochimie 86 (2004) 779-784
46. Ferreira S.M., Lerner S.F., Brunzini R., et al. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 137 (2004) 62-69
47. Ferris F.L. A new treatment for ocular neovascularization. N Engl J Med 351 (2004) 2863-2865
48. Ferris F.L., Chew E.Y., and Hoogwerf B.J. Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care 19 (1996) 1291-1293
49. Flammer F., Orgul S., Costa V.P., et al. The impact of ocular blood flow in glaucoma. Prog Retinal Eye Res 21 (2002) 359-393
50. Flegal K.M., Carroll M.D., Kuczmarski R.J., et al. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22 (1998) 39-47
51. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
52. Ford E.S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22 (1999) 1971-1977
53. Foster P.J., Wong T.Y., Machin D., et al. Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol 87 (2003) 1112-1120
54. Friedman N., and Fanning E.L. Overweight and obesity: an overview of prevalence, clinical impact, and economic impact. Dis Manag 7 Suppl 1 (2004) S1-S6
55. Friedrich M.J. Epidemic of obesity expands its spread to developing countries. JAMA 287 (2002) 1382-1386
56. Frystyk J., Tarnow L., Hansen T.K., et al. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 48 (2005) 1911-1918
57. Gariano R.F., Nath A.K., D'Amico D.J., et al. Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci 41 (2000) 3576-3581
58. Garner M.H., and Spector A. Selective oxidation of cysteine and methionine in normal and senile cataractous lenses. Proc Natl Acad Sci USA 77 (1980) 1274-1277
59. Garofalo C., and Surmacz E. Leptin and cancer. J Cell Physiol 207 (2006) 12-22
60. Gasser P., Stümpfig D., Schötzau A., et al. Body mass index in glaucoma. J Glaucoma 8 (1999) 8-11
61. Gherghel D., Griffiths H.R., Hilton E.J., et al. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 46 (2005) 877-883
62. Głowińska B., Urban M., Hryniewicz A., et al. Endothelin-1 plasma concentration in children and adolescents with atherogenic risk factors. Kardiol Pol 61 (2004) 329-338
63. Glynn R.J., Christen W.G., Manson J.E., et al. Body mass index. An independent predictor of cataract. Arch Ophthalmol 113 (1995) 1131-1137
64. Gómez-Ambrosi J., Salvador J., and Frühbeck G. Is hyperleptinemia involved in the development of age-related lens opacities?. Am J Clin Nutr 79 (2004) 888-889 author reply 889
65. Goodrich M.E., Cumming R.G., Mitchell P., et al. Plasma fibrinogen and other cardiovascular disease risk factors and cataract. Ophthalmic Epidemiol 6 (1999) 279-290
66. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720 discussion 829-30
67. Gragoudas E.S., Adamis A.P., Cunningham E.T., et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
68. Grieshaber M.C., and Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol 16 (2005) 79-83
69. Grundy S.M. Metabolic complications of obesity. Endocrine 13 (2000) 155-165
70. Grunwald J.E., Piltz J., Hariprasad S.M., et al. Optic nerve and choroidal circulation in glaucoma. Invest Ophthalmol Vis Sci 39 (1998) 2329-2336
71. Hak A.E., Stehouwer C.D., Bots M.L., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19 (1999) 1986-1991
72. Halpern D.L., and Grosskreutz C.L. Glaucomatous optic neuropathy: mechanisms of disease. Ophthalmol Clin North Am 15 (2002) 61-68
73. Hankinson S.E., Seddon J.M., Colditz G.A., et al. A prospective study of aspirin use and cataract extraction in women. Arch Ophthalmol 111 (1993) 503-508
74. Harding J.J. Recent studies of risk factors and protective factors for cataract. Curr Opin Ophthalmol 8 (1997) 46-49
75. Harris A., Zarfati D., Zalish M., et al. Reduced cerebrovascular blood flow velocities and vasoreactivity in open-angle glaucoma. Am J Ophthalmol 135 (2003) 144-147
76. Hart P.M., Chakravarthy U., Mackenzie G., et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol 120 (2002) 1029-1038
77. Haslam D.W., and James W.P. Obesity. Lancet 366 (2005) 1197-1209
78. Hassink S.G., Sheslow D.V., de Lancey E., et al. Serum leptin in children with obesity: relationship to gender and development. Pediatrics 98 (1996) 201-203
79. Haynes W.G. Role of leptin in obesity-related hypertension. Exp Physiol 90 (2005) 683-688
80. Haynes W.G., Sivitz W.I., Morgan D.A., et al. Sympathetic and cardiorenal actions of leptin. Hypertension 30 (1997) 619-623
81. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
82. Hennis A., Wu S.Y., Nemesure B., et al. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 110 (2003) 908-914
83. Henricsson M., Nyström L., Blohmé G., et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 26 (2003) 349-354
84. Hered R.W., Rogers S., Zang Y.F., et al. Ophthalmologic features of Prader-Willi syndrome. J Pediatr Ophthalmol Strabismus 25 (1988) 145-150
85. Hill J.O., Catenacci V., and Wyatt H.R. Obesity: overview of an epidemic. Psychiatr Clin North Am 28 (2005) 1-23 vii
86. Hiller R., Podgor M.J., Sperduto R.D., et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 105 (1998) 1244-1250
87. Hirvelä H., Luukinen H., Läärä E., et al. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103 (1996) 871-877
88. Hogg R., and Chakravarthy U. AMD and micronutrient antioxidants. Curr Eye Res 29 (2004) 387-401
89. Holz F.G., Pauleikhoff D., Klein R., et al. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 137 (2004) 504-510
90. Horwitz J. Anatomy and embryology. In: Podos S.M., and Yanoff M. (Eds). Textbook of Ophthalmology 3, Lens and Cataract (1992), Gower Medical Publishing, New York pp 50-55
91. Hyman L., and Neborsky R. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 13 (2002) 171-175
92. Hyman L., Schachat A.P., He Q., et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 118 (2000) 351-358
93. Izzotti A., Saccà S.C., Cartiglia C., et al. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 114 (2003) 638-646
94. Jacques P.F., Moeller S.M., Hankinson S.E., et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr 78 (2003) 400-405
95. Jaén Díaz J., Sanz Alcolea I., López De Castro F., et al. [Glaucoma and ocular hypertension in primary care]. Aten Primaria 28 (2001) 23-30
96. Jahn C.E., Janke M., Winowski H., et al. Identification of metabolic risk factors for posterior subcapsular cataract. Ophthalmic Res 18 (1986) 112-116
97. James P.T. Obesity: the worldwide epidemic. Clin Dermatol 22 (2004) 276-280
98. James P.T., Leach R., Kalamara E., et al. The worldwide obesity epidemic. Obes Res 9 Suppl 4 (2001) 228S-233S
99. Jonas J.B., Grundler A.E., Gonzales-Cortes J., et al. Pressure-dependent neuroretinal rim loss in normal-pressure glaucoma. Am J Ophthalmol 125 (1988) 137-144
100. Kaiser H.J., Flammer J., Wenk M., et al. Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol 233 (1995) 484-488
101. Karasik A., Modan M., Halkin H., et al. Senile cataract and glucose intolerance: the Israel Study of glucose Intolerance Obesity and Hypertension (The Israel GOH Study). Diabetes Care 7 (1984) 52-56
102. Kaur H., Hyder M.L., and Poston W.S. Childhood overweight: an expanding problem. Treat Endocrinol 2 (2003) 375-388
103. Keaney J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439
104. Kennedy R.L., Chokkalingham K., and Srinivasan R. Obesity in the elderly: who should we be treating, and why, and how?. Curr Opin Clin Nutr Metab Care 7 (2004) 3-9
105. Kitazawa Y., Horie T., Aoki S., et al. Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol 95 (1977) 1180-1184
106. Klein B.E., and Klein R. Intraocular pressure and cardiovascular risk variables. Arch Ophthalmol 99 (1981) 837-839
107. Klein B.E., Klein R., and Lee K.E. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126 (1998) 782-790
108. Klein B.E., Klein R., Lee K.E., et al. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol 8 (2001) 251-262
109. Klein B.E., Klein R., and Linton K.L. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 33 (1992) 2224-2228
110. Klein B.E., Klein R., and Moss S.E. Incident cataract surgery: the Beaver Dam eye study. Ophthalmology 104 (1997) 573-580
111. Klein B.E., Moss S.E., Klein R., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 98 (1991) 1261-1265
112. Klein R., Klein B.E., and Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 100 (1993) 406-414
113. Klein R., Klein B.E., and Moss S.E. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 157 (1997) 650-656
114. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102 (1984) 527-532
115. Klein R., Klein B.E., Tomany S.C., et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 110 (2003) 636-643
116. Klein R., Peto T., Bird A., et al. The epidemiology of age-related macular degeneration. Am J Ophthalmol 137 (2004) 486-495
117. Klein R., Sharrett A.R., Klein B.E., et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 109 (2002) 1225-1234
118. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
119. Kohner E.M., Aldington S.J., Stratton I.M., et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 116 (1998) 297-303
120. Kopitz J., Holz F.G., Kaemmerer E., et al. Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie 86 (2004) 825-831
121. Kuang T.M., Tsai S.Y., Hsu W.M., et al. Body mass index and age-related cataract: the Shihpai Eye Study. Arch Ophthalmol 123 (2005) 1109-1114
122. Lahey J.M., Kearney J.J., and Tunc M. Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 9 (2003) 385-392
123. Lawrence V.J., and Kopelman P.G. Medical consequences of obesity. Clin Dermatol 22 (2004) 296-302
124. Lee E.T., Lee V.S., Lu M., et al. Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes 41 (1992) 359-367
125. Lee J.S., Lee S.H., Oum B.S., et al. Relationship between intraocular pressure and systemic health parameters in a Korean population. Clin Experiment Ophthalmol 30 (2002) 237-241
126. Leske M.C., Chylack L.T., and Wu S.Y. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 109 (1991) 244-251
127. Leske M.C., Connell A.M., Wu S.Y., et al. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 113 (1995) 918-924
128. Leske M.C., and Podgor M.J. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol 118 (1983) 280-287
129. Leske M.C., Wu S.Y., Hennis A., et al. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology 106 (1999) 35-41
130. Leske M.C., Wu S.Y., Hyman L., et al. Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group. Arch Ophthalmol 113 (1995) 1113-1119
131. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 37 (1992) 155-166
132. Lim H.S., MacFadyen R.J., and Lip G.Y. Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart. Arch Intern Med 164 (2004) 1737-1748
133. Lobstein T., Baur L., Uauy R., et al. Obesity in children and young people: a crisis in public health. Obes Rev 5 Suppl 1 (2004) 4-104
134. Maier P.C., Funk J., Schwarzer G., et al. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 331 (2005) 134
135. Mapstone R., and Clark C.V. Prevalence of diabetes in glaucoma. Br Med J (Clin Res Ed) 291 (1985) 93-95
136. Marcus D.M., Sheils W., Johnson M.H., et al. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial. Arch Ophthalmol 119 (2001) 171-180
137. Matsuda M., Kawasaki F., Yamada K., et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects. Diabet Med 21 (2004) 881-888
138. McLeod S.D., West S.K., Quigley H.A., et al. A longitudinal study of the relationship between intraocular and blood pressures. Invest Ophthalmol Vis Sci 31 (1990) 2361-2366
139. McNab A.A. The eye and sleep. Clin Experiment Ophthalmol 33 (2005) 117-125
140. Mitchell P., Smith W., Attebo K., et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 103 (1996) 1661-1669
141. Mitchell P., Smith W., Chey T., et al. Open-angle glaucoma and diabetes: the Blue Mountains eye study. Australia. Ophthalmology 104 (1997) 712-718
142. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., et al. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 46 (2003) 1483-1488
143. Moeini H.A., Masoudpour H., and Ghanbari H. A study of the relation between body mass index and the incidence of age related macular degeneration. Br J Ophthalmol 89 (2005) 964-966
144. Mohan M., Sperduto R.D., Angra S.K., et al. India-US case-control study of age-related cataracts. India-US Case-Control Study Group. Arch Ophthalmol 107 (1989) 670-676
145. Moreno M.C., Campanelli J., Sande P., et al. Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 37 (2004) 803-812
146. Mori K., Ando F., Nomura H., et al. Relationship between intraocular pressure and obesity in Japan. Int J Epidemiol 29 (2000) 661-666
147. Nakamura M., Ishimitsu T., Matsuoka H., et al. [Implications of obesity for target organ injuries and cardiovascular risk factors in hypertensive subjects]. Nippon Jinzo Gakkai Shi 39 (1997) 746-752
148. Nakamura M., Kanamori A., and Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica 219 (2005) 1-10
149. Narin F., Atabek M.E., Karakukcu M., et al. The association of plasma homocysteine levels with serum leptin and apolipoprotein B levels in childhood obesity. Ann Saudi Med 25 (2005) 209-214
150. Nelson R.G., Wolfe J.A., Horton M.B., et al. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes 38 (1989) 435-440
151. Nieuwdorp M., Stroes E.S., Meijers J.C., et al. Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 5 (2005) 155-159
152. Oh S.W., Lee S., Park C., et al. Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab Res Rev 21 (2005) 434-440
153. Ohia S.E., Opere C.A., and Leday A.M. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res 579 (2005) 22-36
154. Olney J.W. Inciting excitotoxic cytocide among central neurons. Adv Exp Med Biol 203 (1986) 631-645
155. Pi-Sunyer F.X. Medical hazards of obesity. Ann Intern Med 119 (1993) 655-660
156. Polak M., and Zagórski Z. Lipid peroxidation in diabetic retinopathy. Ann Univ Mariae Curie Sklodowska [Med] 59 (2004) 434-437
157. Prisco D., and Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 32 (2002) 308-311
158. Purvin V.A., Kawasaki A., and Yee R.D. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol 118 (2000) 1626-1630
159. Quigley H.A., Nickells R.W., Kerrigan L.A., et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36 (1995) 774-786
160. Raina J., and Foster J.A. Obesity as a cause of mechanical entropion. Am J Ophthalmol 122 (1996) 123-125
161. Ramachandran S., Morris S.M., Devamanoharan P., et al. Radio-isotopic determination of hydrogen peroxide in aqueous humor and urine. Exp Eye Res 53 (1991) 503-506
162. Robinson M.K., and Halpern J.I. Retinal vein occlusion. Am Fam Physician 45 (1992) 2661-2666
163. Rodríguez de Rivera F.J., Martínez-Sanchez P., Ojeda-Ruiz de Luna J., et al. Benign intracranial hypertension. History, clinical features and treatment in a series of 41 patients]. Rev Neurol 37 (2003) 801-805 115
164. Roth F., Bindewald A., and Holz F.G. Key pathophysiologic pathways in age-related macular disease. Graefes Arch Clin Exp Ophthalmol 242 (2004) 710-716
165. Saccà S.C., Pascotto A., Camicione P., et al. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 123 (2005) 458-463
166. Savinova O.V., Sugiyama F., Martin J.E., et al. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet 2 (2001) 12
167. Schaumberg D.A., Christen W.G., Hankinson S.E., et al. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol 119 (2001) 1259-1265
168. Schaumberg D.A., Glynn R.J., Christen W.G., et al. Relations of body fat distribution and height with cataract in men. Am J Clin Nutr 72 (2000) 1495-1502
169. Schaumberg D.A., Ridker P.M., Glynn R.J., et al. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol 9 (1999) 166-171
170. Schmidt-Erfurth U., Michels S., Michels R., et al. Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Eur J Ophthalmol 15 (2005) 482-485
171. Schoenfeld E.R., Leske M.C., and Wu S.Y. Recent epidemiologic studies on nutrition and cataract in India, Italy and the United States. J Am Coll Nutr 12 (1993) 521-526
172. Schorr U., Blaschke K., Turan S., et al. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 16 (1998) 1475-1480
173. Seddon J.M., Cote J., Davis N., et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121 (2003) 785-792
174. Sheard N.F. Moderate changes in weight and physical activity can prevent or delay the development of type 2 diabetes mellitus in susceptible individuals. Nutr Rev 61 (2003) 76-79
175. Shiose Y. Intraocular pressure: new perspectives. Surv Ophthalmol 34 (1990) 413-435
176. Shiose Y. The aging effect on intraocular pressure in an apparently normal population. Arch Ophthalmol 102 (1984) 883-887
177. Shiose Y., and Kawase Y. A new approach to stratified normal intraocular pressure in a general population. Am J Ophthalmol 101 (1986) 714-721
178. Sierra-Honigmann M.R., Nath A.K., Murakami C., et al. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683-1686
179. Silha J.V., Krsek M., Sucharda P., et al. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) 29 (2005) 1308-1314
180. Sjöström C.D., Lissner L., and Sjöström L. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study. Swedish Obese Subjects. Obes Res 5 (1997) 519-530
181. Sjöström C.D., Lissner L., Wedel H., et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 7 (1999) 477-484
182. Sjöström L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2693
183. Smith W., Assink J., Klein R., et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108 (2001) 697-704
184. Smith W., Mitchell P., Leeder S.R., et al. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116 (1998) 583-587
185. Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol 107 (1989) 186-188
186. Spaide R.F., Armstrong D., and Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration-what is the cause?. Retina 23 (2003) 595-614
187. Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J 9 (1995) 1173-1182
188. Spector A., and Garner W.H. Hydrogen peroxide and human cataract. Exp Eye Res 33 (1981) 673-681
189. Spector A., Wang G.M., and Wang R.R. The prevention of cataract caused by oxidative stress in cultured rat lenses. II. Early effects of photochemical stress and recovery. Exp Eye Res 57 (1993) 659-667
190. Spector A., Wang G.M., Wang R.R., et al. A brief photochemically induced oxidative insult causes irreversible lens damage and cataract. II. Mechanism of action. Exp Eye Res 60 (1995) 483-493
191. Stevens V.J., Obarzanek E., Cook N.R., et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 134 (2001) 1-11
192. Stratton I.M., Kohner E.M., Aldington S.J., et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44 (2001) 156-163
193. Su D.H., and Yeo K.T. Diabetic retinopathy and serum lipids. Singapore Med J 41 (2000) 295-297
194. Suter P.M., Locher R., Hasler E., et al. Is there a role for the ob gene product leptin in essential hypertension?. Am J Hypertens 11 (1998) 1305-1311
195. Tamburrino M.B., and McGinnis R.A. Anorexia nervosa. A review. Panminerva Med 44 (2002) 301-311
196. Tapp R.J., Shaw J.E., Harper C.A., et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26 (2003) 1731-1737
197. Tavani A., Negri E., and La Vecchia C. Selected diseases and risk of cataract in women. A case-control study from northern Italy. Ann Epidemiol 5 (1995) 234-238
198. Taylor A. Nutritional influences on risk for cataract. Int Ophthalmol Clin 40 (2000) 17-49
199. Teuscher A.U., and Meienberg O. Ischaemic oculomotor nerve palsy. Clinical features and vascular risk factors in 23 patients. J Neurol 232 (1985) 144-149
200. Tielsch J.M., Katz J., Sommer A., et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 113 (1995) 216-221
201. Torgerson J.S., Hauptman J., Boldrin M.N., et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27 (2004) 155-161
202. Tuomilehto J., Lindström J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
203. Uckaya G., Ozata M., Bayraktar Z., et al. Is leptin associated with diabetic retinopathy?. Diabetes Care 23 (2000) 371-376
204. Uckaya G., Ozata M., Sonmez A., et al. Is leptin associated with hypertensive retinopathy?. J Clin Endocrinol Metab 85 (2000) 683-687
205. Ughade S.N., Zodpey S.P., and Khanolkar V.A. Risk factors for cataract: a case control study. Indian J Ophthalmol 46 (1998) 221-227
206. Valle V., Martos R., Gascon F., et al. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 31 (2005) 55-62
207. van Leiden H.A., Dekker J.M., Moll A.C., et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 25 (2002) 1320-1325
208. van Leiden H.A., Dekker J.M., Moll A.C., et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121 (2003) 245-251
209. Visser M., Bouter L.M., McQuillan G.M., et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
210. Wachter A., Sun Y., Dasch B., et al. Münster age- and retina study (MARS). Association between risk factors for arteriosclerosis and age-related macular degeneration. Ophthalmologe 101 (2004) 50-53
211. Weintraub J.M., Willett W.C., Rosner B., et al. A prospective study of the relationship between body mass index and cataract extraction among US women and men. Int J Obes Relat Metab Disord 26 (2002) 1588-1595
212. West S.K., and Valmadrid C.T. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol 39 (1995) 323-334
213. Wong T.Y., Duncan B.B., Golden S.H., et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci 45 (2004) 2949-2954
214. Wong T.Y., Larsen E.K., Klein R., et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ophthalmology 112 (2005) 540-547
215. Wong T.Y., and Mitchell P. Hypertensive retinopathy. N Engl J Med 351 (2004) 2310-2317
216. Wood P.D., Stefanick M.L., Dreon D.M., et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 319 (1988) 1173-1179
217. Wormald R., Evans J., Smeeth L., et al. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 4 (2005) CD002030
218. Wu S.Y., and Leske M.C. Associations with intraocular pressure in the Barbados Eye Study. Archives of Ophthalmology 115 (1997) 1572-1576
219. Yamagishi S., Amano S., Inagaki Y., et al. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties. Microvasc Res 65 (2003) 186-190
220. Yilmaz M.I., Sonmez A., Acikel C., et al. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 151 (2004) 135-140
221. Yoshida M., Ishikawa M., Kokaze A., et al. Association of life-style with intraocular pressure in middle-aged and older Japanese residents. Jpn J Ophthalmol 47 (2003) 191-198
222. Younan C., Mitchell P., Cumming R., et al. Cardiovascular disease, vascular risk factors and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Ophthalmic Epidemiol 10 (2003) 227-240
223. Yudkin J.S., Eringa E., and Stehouwer C.D. Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365 (2005) 1817-1820
224. Zanella M.T., Kohlmann O., and Ribeiro A.B. Treatment of obesity hypertension and diabetes syndrome. Hypertension 38 (2001) 705-708
225. Zang E.A., and Wynder E.L. The association between body mass index and the relative frequencies of diseases in a sample of hospitalized patients. Nutr Cancer 21 (1994) 247-261
226. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122 (2004) 598-614
227. Zhang F., Chen Y., Heiman M., et al. Leptin: structure, function and biology. Vitam Horm 71 (2005) 345-372
228. Zhang L., Krzentowski G., Albert A., et al. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24 (2001) 1275-1279
229. Zhou L., Li Y., and Yue B.Y. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J Cell Physiol 180 (1999) 182-189